Geoffrey S. Dow
CIK: 0001977231
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
60 DEGREES PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 12, 2026SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct7.4K shares at avg. $1.38$10K - Dec 15, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct9.7K shares at avg. $0.80$8K - Dec 11, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct3.6K shares at avg. $0.92$3K - Dec 10, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct9.4K shares at avg. $0.95$9K - Sep 12, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Award(A)Direct7.2K shares at avg. $1.39$10K - Jun 9, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Award(A)Direct4.4K shares at avg. $2.99$13K - Jan 17, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Award(A)Direct14.4K shares- - Jan 2, 2025SXTP
60 DEGREES PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
525K shares- - Dec 9, 2024SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct35.8K shares at avg. $1.27$46K - Dec 6, 2024SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct20.6K shares at avg. $1.20$25K - Dec 5, 2024SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct17.5K shares at avg. $1.11$20K - Nov 21, 2024SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct3.5K shares at avg. $0.91$3K - Nov 20, 2024SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct1K shares at avg. $0.92$924.3 - Nov 19, 2024SXTP
60 DEGREES PHARMACEUTICALS, INC.
Purchase(P)Direct2.5K shares at avg. $0.90$2K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 7,350 | $1.38 | $10,131 | Direct |
| Dec 15, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 9,670 | $0.80 | $7,759 | Direct |
| Dec 11, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 3,613 | $0.92 | $3,318 | Direct |
| Dec 10, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 9,350 | $0.95 | $8,886 | Direct |
| Sep 12, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Award(A) | 7,201 | $1.39 | $9,996 | Direct |
| Jun 9, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Award(A) | 4,376 | $2.99 | $13,065 | Direct |
| Jan 17, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Award(A) | 14,394 | - | $0 | Direct |
| Jan 2, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 525,000 | - | - | Direct |
| Dec 9, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 35,823 | $1.27 | $45,563 | Direct |
| Dec 6, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 20,579 | $1.20 | $24,672 | Direct |
| Dec 5, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 17,549 | $1.11 | $19,520 | Direct |
| Nov 21, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 3,500 | $0.91 | $3,195 | Direct |
| Nov 20, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 1,000 | $0.92 | $924 | Direct |
| Nov 19, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | Purchase(P) | 2,500 | $0.90 | $2,248 | Direct |
1-14 of 14 transactions
About DOW GEOFFREY S
DOW GEOFFREY S (SEC CIK 0001977231) files insider reports with the SEC as President and CEO of 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
Signal8 holds 9 ownership filings by DOW GEOFFREY S, all Form 4s, filed between Nov 21, 2024 and Jun 15, 2026. Those filings report 14 transactions, from Nov 19, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DOW GEOFFREY S's filings is in WASHINGTON, DC.
Recent filings by DOW GEOFFREY S
- Jun 12, 2026: Open-market purchase of SXTP shares (Form 4, code P).
- Dec 15, 2025: Open-market purchase of SXTP shares (Form 4, code P).
- Dec 11, 2025: Open-market purchase of SXTP shares (Form 4, code P).
- Dec 10, 2025: Open-market purchase of SXTP shares (Form 4, code P).
- Sep 12, 2025: Grant or award of SXTP shares (Form 4, code A).
Other insiders filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Knight Therapeutics Inc., 10% Owner
- Francois Eric, Director
- Landon Kristen, Chief Operating Officer
- XU CHERYL, Director
- MILLER TYRONE, CFO